Research funding

2023 - 2026 Czech Health Research Concil - Project No. NU23-03-00562 "Development of resistance mechanisms to FLT3 inhibitors; role of bone marrow microenvironment" - (main researcher: Assoc. Prof. PharmDr. Martina Čečková, Ph.D. ; co-investigator: prof. MUDr. Pavel Žák, Ph.D.)
2023 - 2026 Czech Health Research Concil - Project No. NU23-08-00439 "Novel agents inhibiting FLT3-tyrosine kinase for the treatment of leukemia" - (main researcher: Assoc. Prof. PharmDr. Jan Korábečný, Ph.D.; co-investigator: Assoc. Prof. PharmDr. Martina Čečková, Ph.D. and Prof. MUDr. Martina Řezáčová, Ph.D.

2022 – 2024 Grant Agency of Charles University: “Novel anti - AML drugs and their role in the resistance of leukemic cells” (No. 225001), main researcher - MSc. Fahda Ahmed)

2020 – 2022 Charles University – PRIMUS: “Pharmacokinetic mechanisms of drug resistance in acute myeloid leukemia, their affecting and regulation” (PRIMUS/20/MED/010, main researcher - Assoc. Prof. Dr. Martina Čečková)
2020 – 2022 Grant Agency of Charles University: “Evaluation of ABC transporters in acute myeloid leukemia and their interaction with novel FLT3 inhibitors as a potential promising therapeutic strategy” (205019, main researcher - Mgr. Simona Suchá)
2020 – 2022 The Czech Science Foundation: “Study on the role of novel targeted breast and lung anticancer drugs in the phenomenon of pharmacokinetic drug resistance“ (20-20414Y, co-researcher - Assoc. Prof. Dr. Martina Čečková)
2018 – 2022 Operation Programme Research, Development and Education: “Efficiency and Safety Improvement of Current Drugs and Nutraceuticals: Advanced Methods – New Challenges” (CZ.02.1.01/0.0/0.0/16_019/0000841, junior scientist - Assoc. Prof. Dr. Martina Čečková)
2016 – 2018 Grant Agency of Charles University: “Study of interactions of novel antiretroviral drugs with placental drug transporters” (616216/C, main researcher - Mgr. Lenka Ťupová)

2015 – 2017 Grant Agency of Charles University: “Study of interactions of cyclin-dependent kinases with drug efflux transporters ABCB1, ABCG2 and ABCC1” (344315/C, main researcher - Mgr. Aleš Šorf)

2013 – 2016 The Czech Science Foundation: “Interactions of antiretroviral drugs with human drug transporters in vitro in consideration of transplacental pharmacokinetics“ (GP13-31118P, main researcher - Assoc. Prof. Dr. Martina Čečková)